DelMar Pharmaceuticals Announces Approval for Listing on NASDAQ
3:19 PM July 11, 2016DMPI to Begin Trading on NASDAQ Capital Market on July 12, 2016 VANCOUVER, British Columbia and MENLO PARK, Calif., July 11, 2016, DMPI, /PRNewswire/ — DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) (“DelMar” and the “Company”), a company focused on developing and commercializing proven cancer therapies in new orphan drug indications, announced today that it has received approval from the Nasdaq Stock Market LLC (“NASDAQ”) for the listing of its common stock on the NASDAQ Capital Market. DelMar’s common stock will begin
Read more